| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 31,761 | 53,583 | ||
| Prepaid expenses and other current assets | 23,537 | 4,116 | ||
| Total current assets | 55,298 | 57,699 | ||
| Total assets | 55,298 | 57,699 | ||
| Accounts payable | 133,759 | 133,808 | ||
| Accrued compensation | 4,135,109 | 4,011,998 | ||
| Accrued consulting | 787,903 | 787,903 | ||
| Accrued expenses and other | 658,047 | 636,632 | ||
| Loan payable | 200,000 | 200,000 | ||
| Total current liabilities | 5,914,818 | 5,770,341 | ||
| Convertible notes, net | 1,447,363 | 1,428,880 | ||
| Total liabilities | 7,362,181 | 7,199,221 | ||
| Preferred stock, value-Series APreferred Stock | 0 | 0 | ||
| Preferred stock, value | - | 0 | ||
| Preferred stock, value-Series BPreferred Stock | 1 | 1 | ||
| Common stock, 0.00001 par value 100,000,000 shares authorized 7,242,137 shares issued and outstanding | 72 | 72 | ||
| Additional paid-in capital | 2,050,073 | 2,050,073 | ||
| Accumulated deficit | -9,357,029 | -9,191,668 | ||
| Total stockholders deficit | -7,306,883 | -7,141,522 | ||
| Total liabilities and stockholders deficit | 55,298 | 57,699 | ||
Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic ImmunoEngineering Inc. (CPMV)